The effect of platelet activating factor on different phases of murine in vitro fertilization

H Shi1, F Miller, K Miller

  • 1Department of Obstetrics and Gynecology, Ohio State University Hospitals, Columbus 43210.

Abstract

Insights

Platelet activating factor (PAF) at 10(-6) M significantly enhances mouse in vitro fertilization rates when applied during sperm capacitation and oocyte coincubation. Further PAF treatment offers no additional benefit to fertilization or embryo development.

Area of Science:

  • Reproductive Biology
  • Cell Signaling

Background:

  • Platelet activating factor (PAF) is a bioactive lipid mediator.
  • Understanding PAF's role in fertilization is crucial for improving in vitro fertilization (IVF) success rates.

Purpose of the Study:

  • To investigate the impact of PAF on different stages of mouse in vitro fertilization.
  • To determine optimal PAF parameters for enhancing fertilization rates.

Main Methods:

  • Mouse in vitro fertilization was performed with varying PAF concentrations (10(-7) to 10(-5) M).
  • PAF was applied during sperm capacitation, sperm/oocyte coincubation, and preimplantation embryo growth phases.
  • Three experimental groups received PAF treatment in one, two, or all three phases.

Main Results:

  • PAF treatment increased fertilization rates by 6.5% to 19.0% compared to controls (P < 0.05-P < 0.001).
  • Optimal enhancement was observed with 10(-6) M PAF during sperm capacitation and sperm/oocyte coincubation.
  • No additional benefit was seen when PAF treatment extended beyond the coincubation phase.

Conclusions:

  • A PAF concentration of 10(-6) M during sperm capacitation and coincubation maximizes fertilization improvement in mice.
  • Sustained PAF treatment post-coincubation does not enhance fertilization or subsequent embryo development.